Seven Cases of Guillain-Barr é Noted After COVID-19 Vaccine in India

MONDAY, June 28, 2021 -- Cases of Guillain-Barr é syndrome (GBS) have been reported after receipt of the Oxford-AstraZeneca severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, according to two reports published online June 10 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news